medigraphic.com
ENGLISH

Cardiovascular and Metabolic Science

ISSN 2954-3835 (Digital)
ISSN 2683-2828 (Impreso)
Antes Revista Mexicana de Cardiología

Ver Revista Mexicana de Cardiología


  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
    • Envío de artículos
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2020, Número S3

<< Anterior

Cardiovasc Metab Sci 2020; 31 (S3)


Tratamiento del paro cardiaco en adultos, niños y neonatos con COVID-19.
Recomendaciones de la Sociedad Interamericana de Cardiología (SIAC), Asociación Nacional de Cardiólogos de México (ANCAM) y Sociedad Mexicana de Cardiología (SMC)

Rodríguez-Reyes H, Ortiz-Galván F, Ibarrola M, Celaya-Cota M, Dubner S, Asensio-Lafuente E, Núñez AE, Mendoza-Novoa P, Muñoz-Gutiérrez M, Sarquella-Brugada G, Mendoza I, Márquez M
Texto completo Cómo citar este artículo 10.35366/93960

DOI

DOI: 10.35366/93960
URL: https://dx.doi.org/10.35366/93960
Artículos similares

Idioma: Inglés [English version]
Referencias bibliográficas: 26
Paginas: 285-296
Archivo PDF: 629.26 Kb.


PALABRAS CLAVE

Reanimación cardiopulmonar, paro cardiaco, COVID-19, coronavirus, personal sanitario, recomendaciones.

RESUMEN

La pandemia COVID-19 presenta un gran impacto en la población general, pero ha cobrado un número especialmente alto de víctimas entre el personal sanitario. Los esfuerzos de reanimación requieren posibles modificaciones de las actuales directrices internacionales sobre reanimación cardiopulmonar (RCP) debido a la tasa de infección del nuevo virus del SARS-CoV-2. Se ha visto que hasta el 15% de los pacientes de COVID-19 tienen una enfermedad grave, el 5% tiene una forma crítica de infección y la tasa media de mortalidad es del 3%, aunque hay diferencias significativas según el país que lo informe y las condiciones de base de los pacientes que incluyen la edad, la presencia de hipertensión arterial, la obesidad, la diabetes y las enfermedades cardiovasculares. En estos sujetos de alto riesgo, la mortalidad puede llegar al 24%. También hay informes de un reciente aumento de víctimas de paro cardiaco fuera del hospital. El paro cardiaco (PC) en estos sujetos podría estar relacionado con muchas causas, pero aparentemente, ese fenómeno se relaciona con enfermedades respiratorias más que con problemas cardiacos. En este contexto, la decisión de iniciar o continuar las maniobras de reanimación cardiopulmonar debe evaluarse cuidadosamente, debido a la baja tasa de supervivencia registrada hasta ahora y al alto riesgo de contagio entre el personal sanitario.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Edelson DP, Sasson C, Chan PS et al. Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Care Committee and Get With the Guidelines®-Resuscitation Adult and Pediatric Task Forces of the American Heart Association in Collaboration with the American Academy of Pediatrics, American Association for Respiratory Care, American College of Emergency Physicians, The Society of Critical Care Anesthesiologists, and American Society of Anesthesiologists: Supporting Organizations: American Association of Critical Care Nurses and National EMS Physicians [published online ahead of print, 2020 Apr 9]. Circulation. 2020; 10.1161/ CIRCULATIONAHA.120.047463. doi:10.1161/CIRCULATIONAHA. 120.047463.

  2. WHO. COVID-19 Strategy update 14 April 2020. Available in: https//www.who.int/emergencies/diseases/ novel-coronavirus-2019/strategies-plans-and-operations

  3. Richardson S, Hirsch JS, Narasimham M, Crawford JM, McGinn T, Davidson KW et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020. doi: 10.1001/jama.2020.6775.

  4. Baldi E, Sechi GM, Mare C, Cnevari F, Brancaglione A. Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy [published online ahead of print, 2020 Apr 29]. N Engl J Med. 2020; NEJMc2010418. doi: 10.1056/NEJMc2010418.

  5. D’Ambrosio A. “Probable” COVID-19 Death Reporting Varies by State – Authorities wrestle with fatal cases that look like COVID but lack test confirmation. April 23, 2020. Available in: https://www.medpagetoday. com/infectiousdisease/covid19/86127?xid=nl_ medpageexclusive_2020-04-24&eun=g728008d0r&utm_ source=Sailthru&utm_medium=email&utm_campaign= MPTExclusives_042420&utm_term=NL_Gen_Int_Medpage_ Exclusives_Active

  6. Shao F, Xu S, Ma X et al. In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China [published online ahead of print, 2020 Apr 10]. Resuscitation. 2020; 151: 18‐23. doi: 10.1016/j. resuscitation.2020.04.005.

  7. Lane J, Weaves J, Kostka K, Duarte-Salles T, Abrahao MT, Alghoul H et al. Safety of Hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study. medRxiv. Available in: http//doi.org/10.1101/2020.04.08.20054551

  8. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. Last update on 21 April 2020. Available in: Escardio.org/Education/ COVID-19-and-Cardiology/ESC-COVID-19-Guidance

  9. CDC, update April 13, 2020. Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in healthcare Settings. Available in: www. cdc.gov/coronavirus/2019-ncov/hcp/infection-control

  10. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [published online ahead of print, 2020 Feb 24]. JAMA. 2020; 10.1001/jama.2020.2648. doi: 10.1001/ jama.2020.2648.

  11. Rodríguez Jiménez A, Yared Meraz A. COVID-19: desde la línea de fuego. Disponible en: https://espanol. medscape.com/verarticulo/5905284_1

  12. Rose C. Am I Part of the Cure or Am I Part of the Disease? keeping coronavirus out when a doctor comes home. N Engl J Med. 2020; 382 (18): 1684‐1685. doi: 10.1056/ NEJMp2004768.

  13. Delgado D, Wyss Quintana F, Perez G et al. Personal Safety during the COVID-19 pandemic: realities and perspectives of healthcare workers in Latin America. Int J Environ Res Public Health. 2020; 17 (8): 2798. doi: 10.3390/ijerph17082798.

  14. Zhan M, Qin Y, Xue X, Zhu S. Death from COVID-19 of 23 Health Care Workers in China [published online ahead of print, 2020 Apr 15]. N Engl J Med. 2020; NEJMc2005696. doi: 10.1056/NEJMc2005696.

  15. Wang D, Hu B, Hu C et al. Clinical Characteristics of 138 hospitalized patients with 2019 Novel Coronavirus- Infected Pneumonia in Wuhan, China [published online ahead of print, 2020 Feb 7]. JAMA. 2020; 323 (11): 1061‐1069. doi: 10.1001/jama.2020.1585.

  16. BusinessDay, 17/04/2020. Available in: https://www. businesslive.co.za/bd/world/europe/2020-04-17-about- 17000-italian-healthcare-workers-have-covid-19/

  17. The New York Times, Virus Knocks Thousands of Health Workers Out of Action in Europe. Available in: https://www.nytimes.com/2020/03/24/world/europe/ coronarvirus-europe-covid-19.html

  18. Hunter E, Price DA, Murphy E et al. First experience of COVID-19 screening of health-care workers in England. Lancet. 2020; 395 (10234): e77‐e78. doi: 10.1016/S0140- 6736(20)30970-3.

  19. Burrer SL, de Perio MA, Hughes MM, Kuhar DT, Luckhaupt SE, McDaniel CJ et al. Characteristics of health care personnel with COVID-19 – United States, February 12-April 9, 2020. US Department of Health and Human Services/Center for Disease Control and Prevention. MMWR. 2020; 69 (15): 477-481.

  20. Medscape. Viernes 24 de abril, 2020. Disponible en: https:// espanol.medscape.com/verarticulo/5905310?src=mkm_ latmkt_200424_mscmrk_escoronavirus_

  21. Hwang SY, Yoon H, Yoon A et al. N95 filtering facepiece respirators do not reliably afford respiratory protection during chest compression: a simulation study. Am J Emerg Med. 2020; 38 (1): 12‐17.

  22. CDC Severe Acute Respiratory Syndrome. Sequence for donning and removing personal protective equipment (PPE). Available in: https://www.cdc.gov/sars/ downloads/ppeposter1322.pdf

  23. OMS. Pasos para colocar y retirar equipo de protección personal. Disponible en: https://www.who.int/csr/ resources/publications/ebola/ppe-steps/es/

  24. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol. 2018; 72: e91-220. Available in: https:// doi.org/10.1016/j.jacc.2017.10.054

  25. Thomas SH, Behr ER. Pharmacological treatment of acquired QT prolongation and torsades de pointes. Br J Clin Pharmacol. 2016; 81 (3): 420‐427. doi: 10.1111/ bcp.12726.

  26. Kramer DB, Lo B, Dickert NW. CPR in the COVID-19 Era - an ethical framework [published online ahead of print, 2020 May 6]. N Engl J Med. 2020; 10.1056/ NEJMp2010758. doi: 10.1056/NEJMp2010758.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Cardiovasc Metab Sci . 2020;31

ARTíCULOS SIMILARES

CARGANDO ...